How should we measure medication adherence in clinical trials and practice?

Jeannie K Lee, Karen A. Grace, Terri G. Foster, Monica J. Crawley, Goldina I. Erowele, Hazel J. Sun, Phuong T. Turner, Lance E. Sullenberger, Allen J. Taylor

Research output: Contribution to journalArticle

43 Citations (Scopus)

Abstract

Objective: To determine if simple adherence measures, such as twenty-four hour recall and refill history, are accurate for routine use, compared to more time-consuming measures such as pill counts. Design: Randomized, double-blind, placebo-controlled trial. Setting: Walter Reed Army Medical Center, a tertiary medical center in Washington. Patients: Men and women >30 years old with known coronary heart disease and taking a statin medication. Intervention: Clinical pharmacists met with patients for adherence assessments. Main outcome measures: Adherence was measured by pill counts, twenty-four hour recall by patient, and refill history per computer record. Temporal changes in these adherence measures were assessed using general linear models for repeated measures. Results: Adherence was consistently greater for the experimental agent than for the statin therapy (n = 148). Mean pill count adherence for statin drug was 78.7 ± 25.2% compared to 93.5 ± 11.6% (P < 0.001) for the study agent. Refill history and twenty-four hour recall inaccurately measured adherence when compared to pill counts. Adherence, as determined by pill count, for both experimental (P = 0.029) and statin therapy (P = 0.015) showed significant variability across time in general linear models. Neither refill history nor twenty-four hour recall was sensitive to temporal changes. Conclusions: Twenty-four hour recall and refill history inaccurately measure medication adherence for both clinical trial and clinical practice pharmacotherapies. Further, these measures are insensitive to changes in adherence. For a single or multiple assessments across time, pill count more accurately measures medication adherence. Pill count should be the standard for monitoring medication adherence for both clinical trials and clinical practice.

Original languageEnglish (US)
Pages (from-to)685-690
Number of pages6
JournalTherapeutics and Clinical Risk Management
Volume3
Issue number4
StatePublished - 2007
Externally publishedYes

Fingerprint

Hydroxymethylglutaryl-CoA Reductase Inhibitors
Medication Adherence
medication
History
Clinical Trials
Drug therapy
history
linear model
Linear Models
Monitoring
pharmacist
heart disease
Patient Compliance
Pharmacists
Coronary Disease
military
Placebos
Outcome Assessment (Health Care)
monitoring
drug

Keywords

  • Adherence
  • Hyperlipidemia
  • Niacin
  • Pharmacist
  • Pill count
  • Simvastatin

ASJC Scopus subject areas

  • Pharmacology (medical)
  • Medicine(all)
  • Pharmacology, Toxicology and Pharmaceutics(all)
  • Safety Research
  • Chemical Health and Safety

Cite this

Lee, J. K., Grace, K. A., Foster, T. G., Crawley, M. J., Erowele, G. I., Sun, H. J., ... Taylor, A. J. (2007). How should we measure medication adherence in clinical trials and practice? Therapeutics and Clinical Risk Management, 3(4), 685-690.

How should we measure medication adherence in clinical trials and practice? / Lee, Jeannie K; Grace, Karen A.; Foster, Terri G.; Crawley, Monica J.; Erowele, Goldina I.; Sun, Hazel J.; Turner, Phuong T.; Sullenberger, Lance E.; Taylor, Allen J.

In: Therapeutics and Clinical Risk Management, Vol. 3, No. 4, 2007, p. 685-690.

Research output: Contribution to journalArticle

Lee, JK, Grace, KA, Foster, TG, Crawley, MJ, Erowele, GI, Sun, HJ, Turner, PT, Sullenberger, LE & Taylor, AJ 2007, 'How should we measure medication adherence in clinical trials and practice?', Therapeutics and Clinical Risk Management, vol. 3, no. 4, pp. 685-690.
Lee JK, Grace KA, Foster TG, Crawley MJ, Erowele GI, Sun HJ et al. How should we measure medication adherence in clinical trials and practice? Therapeutics and Clinical Risk Management. 2007;3(4):685-690.
Lee, Jeannie K ; Grace, Karen A. ; Foster, Terri G. ; Crawley, Monica J. ; Erowele, Goldina I. ; Sun, Hazel J. ; Turner, Phuong T. ; Sullenberger, Lance E. ; Taylor, Allen J. / How should we measure medication adherence in clinical trials and practice?. In: Therapeutics and Clinical Risk Management. 2007 ; Vol. 3, No. 4. pp. 685-690.
@article{04fcd5e98c024d7ab2bafec9e820da8d,
title = "How should we measure medication adherence in clinical trials and practice?",
abstract = "Objective: To determine if simple adherence measures, such as twenty-four hour recall and refill history, are accurate for routine use, compared to more time-consuming measures such as pill counts. Design: Randomized, double-blind, placebo-controlled trial. Setting: Walter Reed Army Medical Center, a tertiary medical center in Washington. Patients: Men and women >30 years old with known coronary heart disease and taking a statin medication. Intervention: Clinical pharmacists met with patients for adherence assessments. Main outcome measures: Adherence was measured by pill counts, twenty-four hour recall by patient, and refill history per computer record. Temporal changes in these adherence measures were assessed using general linear models for repeated measures. Results: Adherence was consistently greater for the experimental agent than for the statin therapy (n = 148). Mean pill count adherence for statin drug was 78.7 ± 25.2{\%} compared to 93.5 ± 11.6{\%} (P < 0.001) for the study agent. Refill history and twenty-four hour recall inaccurately measured adherence when compared to pill counts. Adherence, as determined by pill count, for both experimental (P = 0.029) and statin therapy (P = 0.015) showed significant variability across time in general linear models. Neither refill history nor twenty-four hour recall was sensitive to temporal changes. Conclusions: Twenty-four hour recall and refill history inaccurately measure medication adherence for both clinical trial and clinical practice pharmacotherapies. Further, these measures are insensitive to changes in adherence. For a single or multiple assessments across time, pill count more accurately measures medication adherence. Pill count should be the standard for monitoring medication adherence for both clinical trials and clinical practice.",
keywords = "Adherence, Hyperlipidemia, Niacin, Pharmacist, Pill count, Simvastatin",
author = "Lee, {Jeannie K} and Grace, {Karen A.} and Foster, {Terri G.} and Crawley, {Monica J.} and Erowele, {Goldina I.} and Sun, {Hazel J.} and Turner, {Phuong T.} and Sullenberger, {Lance E.} and Taylor, {Allen J.}",
year = "2007",
language = "English (US)",
volume = "3",
pages = "685--690",
journal = "Therapeutics and Clinical Risk Management",
issn = "1176-6336",
publisher = "Dove Medical Press Ltd.",
number = "4",

}

TY - JOUR

T1 - How should we measure medication adherence in clinical trials and practice?

AU - Lee, Jeannie K

AU - Grace, Karen A.

AU - Foster, Terri G.

AU - Crawley, Monica J.

AU - Erowele, Goldina I.

AU - Sun, Hazel J.

AU - Turner, Phuong T.

AU - Sullenberger, Lance E.

AU - Taylor, Allen J.

PY - 2007

Y1 - 2007

N2 - Objective: To determine if simple adherence measures, such as twenty-four hour recall and refill history, are accurate for routine use, compared to more time-consuming measures such as pill counts. Design: Randomized, double-blind, placebo-controlled trial. Setting: Walter Reed Army Medical Center, a tertiary medical center in Washington. Patients: Men and women >30 years old with known coronary heart disease and taking a statin medication. Intervention: Clinical pharmacists met with patients for adherence assessments. Main outcome measures: Adherence was measured by pill counts, twenty-four hour recall by patient, and refill history per computer record. Temporal changes in these adherence measures were assessed using general linear models for repeated measures. Results: Adherence was consistently greater for the experimental agent than for the statin therapy (n = 148). Mean pill count adherence for statin drug was 78.7 ± 25.2% compared to 93.5 ± 11.6% (P < 0.001) for the study agent. Refill history and twenty-four hour recall inaccurately measured adherence when compared to pill counts. Adherence, as determined by pill count, for both experimental (P = 0.029) and statin therapy (P = 0.015) showed significant variability across time in general linear models. Neither refill history nor twenty-four hour recall was sensitive to temporal changes. Conclusions: Twenty-four hour recall and refill history inaccurately measure medication adherence for both clinical trial and clinical practice pharmacotherapies. Further, these measures are insensitive to changes in adherence. For a single or multiple assessments across time, pill count more accurately measures medication adherence. Pill count should be the standard for monitoring medication adherence for both clinical trials and clinical practice.

AB - Objective: To determine if simple adherence measures, such as twenty-four hour recall and refill history, are accurate for routine use, compared to more time-consuming measures such as pill counts. Design: Randomized, double-blind, placebo-controlled trial. Setting: Walter Reed Army Medical Center, a tertiary medical center in Washington. Patients: Men and women >30 years old with known coronary heart disease and taking a statin medication. Intervention: Clinical pharmacists met with patients for adherence assessments. Main outcome measures: Adherence was measured by pill counts, twenty-four hour recall by patient, and refill history per computer record. Temporal changes in these adherence measures were assessed using general linear models for repeated measures. Results: Adherence was consistently greater for the experimental agent than for the statin therapy (n = 148). Mean pill count adherence for statin drug was 78.7 ± 25.2% compared to 93.5 ± 11.6% (P < 0.001) for the study agent. Refill history and twenty-four hour recall inaccurately measured adherence when compared to pill counts. Adherence, as determined by pill count, for both experimental (P = 0.029) and statin therapy (P = 0.015) showed significant variability across time in general linear models. Neither refill history nor twenty-four hour recall was sensitive to temporal changes. Conclusions: Twenty-four hour recall and refill history inaccurately measure medication adherence for both clinical trial and clinical practice pharmacotherapies. Further, these measures are insensitive to changes in adherence. For a single or multiple assessments across time, pill count more accurately measures medication adherence. Pill count should be the standard for monitoring medication adherence for both clinical trials and clinical practice.

KW - Adherence

KW - Hyperlipidemia

KW - Niacin

KW - Pharmacist

KW - Pill count

KW - Simvastatin

UR - http://www.scopus.com/inward/record.url?scp=34848862734&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34848862734&partnerID=8YFLogxK

M3 - Article

C2 - 18472991

AN - SCOPUS:34848862734

VL - 3

SP - 685

EP - 690

JO - Therapeutics and Clinical Risk Management

JF - Therapeutics and Clinical Risk Management

SN - 1176-6336

IS - 4

ER -